One qualifier I brought up before is frequency of dosing. This calculation assumes that those treated get a treatment course every year. That may not be the case, and we don’t have data on the durability as yet. But suppose on average the treatment is applied every second year. That would halve the revenue.
I still like those numbers.
One qualifier I brought up before is frequency of dosing. This...
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
20.5¢ |
Change
0.010(5.13%) |
Mkt cap ! $68.29M | |||
| Open | High | Low | Value | Volume |
| 20.0¢ | 20.5¢ | 20.0¢ | $33.23K | 165.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 47906 | 20.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 20.5¢ | 20000 | 1 |
View Market Depth
| Last trade - 10.18am 09/10/2024 (20 minute delay) ? |
| PAR (ASX) Chart |